323 related articles for article (PubMed ID: 17194169)
1. Drug-induced musculoskeletal disorders.
Bannwarth B
Drug Saf; 2007; 30(1):27-46. PubMed ID: 17194169
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced myopathies.
Bannwarth B
Expert Opin Drug Saf; 2002 May; 1(1):65-70. PubMed ID: 12904161
[TBL] [Abstract][Full Text] [Related]
3. Musculoskeletal adverse drug reactions: a review of literature and data from ADR spontaneous reporting databases.
Conforti A; Chiamulera C; Moretti U; Colcera S; Fumagalli G; Leone R
Curr Drug Saf; 2007 Jan; 2(1):47-63. PubMed ID: 18690950
[TBL] [Abstract][Full Text] [Related]
4. Drug-induced rheumatic disorders: incidence, prevention and management.
Vergne P; Bertin P; Bonnet C; Scotto C; Trèves R
Drug Saf; 2000 Oct; 23(4):279-93. PubMed ID: 11051216
[TBL] [Abstract][Full Text] [Related]
5. Musculoskeletal pain associated with corticosteroid therapy in cancer.
Frieze DA
Curr Pain Headache Rep; 2010 Aug; 14(4):256-60. PubMed ID: 20490741
[TBL] [Abstract][Full Text] [Related]
6. A VigiBase descriptive study of fluoroquinolone induced disabling and potentially permanent musculoskeletal and connective tissue disorders.
Huruba M; Farcas A; Leucuta DC; Bucsa C; Sipos M; Mogosan C
Sci Rep; 2021 Jul; 11(1):14375. PubMed ID: 34257376
[TBL] [Abstract][Full Text] [Related]
7. Musculoskeletal disorders associated with HIV infection and AIDS. Part II: non-infectious musculoskeletal conditions.
Tehranzadeh J; Ter-Oganesyan RR; Steinbach LS
Skeletal Radiol; 2004 Jun; 33(6):311-20. PubMed ID: 15127244
[TBL] [Abstract][Full Text] [Related]
8. Musculoskeletal features of disorders of lipid metabolism and multicentric reticulohistiocytosis.
Bardin T
Curr Opin Rheumatol; 2004 Jan; 16(1):76-9. PubMed ID: 14673393
[TBL] [Abstract][Full Text] [Related]
9. Musculoskeletal and Rheumatic Diseases Induced by Immune Checkpoint Inhibitors: A Review of the Literature.
Benfaremo D; Manfredi L; Luchetti MM; Gabrielli A
Curr Drug Saf; 2018; 13(3):150-164. PubMed ID: 29745339
[TBL] [Abstract][Full Text] [Related]
10. [Lipid lowering drug and other toxic myopathies].
Schoser BG; Pongratz D
Internist (Berl); 2005 Nov; 46(11):1198-206. PubMed ID: 16151787
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced osteoporosis/osteomalacia: analysis in the French and Spanish pharmacovigilance databases.
Dardonville Q; Salguiero E; Rousseau V; Chebane L; Faillie JL; Gautier S; Montastruc JL; Carvajal A; Bagheri H
Eur J Clin Pharmacol; 2019 Dec; 75(12):1705-1711. PubMed ID: 31468068
[TBL] [Abstract][Full Text] [Related]
12. [Hyperlipidemia and osteoarticular manifestations].
Goupille P; Soutif D; Fouquet B; Valat JP
Rev Med Interne; 1991; 12(2):146-52. PubMed ID: 1852998
[TBL] [Abstract][Full Text] [Related]
13. Medication-induced adverse effects: important concepts for the hand therapist.
Riche DM; Cleary JD; King ST
J Hand Ther; 2010; 23(2):230-6; quiz 237. PubMed ID: 20189757
[TBL] [Abstract][Full Text] [Related]
14. An MRI study of immune checkpoint inhibitor-induced musculoskeletal manifestations myofasciitis is the prominent imaging finding.
Daoussis D; Kraniotis P; Filippopoulou A; Argiriadi R; Theodoraki S; Makatsoris T; Koutras A; Kehagias I; Papachristou DJ; Solomou A; Kalofonos H; Liossis SN
Rheumatology (Oxford); 2020 May; 59(5):1041-1050. PubMed ID: 32344435
[TBL] [Abstract][Full Text] [Related]
15. HIV-associated musculoskeletal involvement.
Marquez J; Candia L; Restrepo CS; Espinoza LR
AIDS Read; 2004 Apr; 14(4):175-9, 183-4. PubMed ID: 15116698
[TBL] [Abstract][Full Text] [Related]
16. Aromatase Inhibitor Symptom Management Practices: A Retrospective Study.
Ernst A; Flynn KE; Weil EM; Crotty BH; Kamaraju S; Fergestrom N; Neuner J
Clin Breast Cancer; 2021 Feb; 21(1):e38-e47. PubMed ID: 33183969
[TBL] [Abstract][Full Text] [Related]
17. Injectable Corticosteroids: Take Precautions and Use Caution.
Freire V; Bureau NJ
Semin Musculoskelet Radiol; 2016 Nov; 20(5):401-408. PubMed ID: 28002861
[TBL] [Abstract][Full Text] [Related]
18. Association of musculoskeletal complaints and gliptin use: review of spontaneous reports.
Tarapués M; Cereza G; Figueras A
Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1115-8. PubMed ID: 23960039
[TBL] [Abstract][Full Text] [Related]
19. [Musculoskeletal adverse drug reactions].
Fournier PE; Revaz S
Rev Med Suisse; 2011 Aug; 7(304):1529-32. PubMed ID: 21919390
[TBL] [Abstract][Full Text] [Related]
20. Corticosteroid-induced adverse events in adults: frequency, screening and prevention.
Fardet L; Kassar A; Cabane J; Flahault A
Drug Saf; 2007; 30(10):861-81. PubMed ID: 17867724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
